They had a hazard ratio for overall survival (OS HR) of 1.70 compared to those treated with splenectomy and chemotherapy, although this difference did not reach statistical significance (Table 2 ).
← all excerpts
Real-world evidence couples genomic biomarkers with therapeutic outcomes for canine hemangiosarcoma.
1
—
—